3-Bromo-6,7-dihydro-5H-pyrrolo[1,2-a]imidazole(CAS: 914637-88-0)

The compound 3-Bromo-6,7-dihydro-5H-pyrrolo[1,2-a]imidazole (CAS: 914637-88-0) should comply with the Globally Harmonized System (GHS) for classification and labeling, the REACH regulation in the European Union, and FDA and EPA requirements for handling and sale in the United States. Specific safety data sheets (SDS) should be prepared to ensure all regulatory guidelines are followed.

Several alternatives can be used in the synthesis of 3-Bromo-6,7-dihydro-5H-pyrrolo[1,2-a]imidazole (CAS: 914637-88-0), such as bromination of other heterocycles or the use of other functional groups. Common reagents like N-bromosuccinimide (NBS) or N-iodosuccinimide (NIS) can serve as brominating agents in similar reactions.

The market for 3-Bromo-6,7-dihydro-5H-pyrrolo[1,2-a]imidazole (CAS: 914637-88-0) is currently focused on its use in medicinal chemistry and drug development. Research trends indicate increasing interest in its potential as a lead compound for treating various diseases, with ongoing investigations into its pharmacological properties and mechanisms of action.

Waste containing 3-Bromo-6,7-dihydro-5H-pyrrolo[1,2-a]imidazole (CAS: 914637-88-0) should be collected in appropriate containers and disposed of through professional waste disposal services that follow environmental protection regulations. Incineration may be used for disposal, but it must be conducted in an enclosed and controlled environment to prevent environmental contamination.